Si-Xue Cheng Selected Research

AGRO 100

10/2023	A Multifunctional Delivery System for Remodulating Cell Behaviors of Circulating Malignant Cells to Prevent Cell Fusion.
4/2020	Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression.
1/2020	Facile Strategy To Enhance Specificity and Sensitivity of Molecular Beacons by an Aptamer-Functionalized Delivery Vector.
10/2019	Multifunctional Albumin-Based Delivery System Generated by Programmed Assembly for Tumor-Targeted Multimodal Therapy and Imaging.
7/2019	Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing.
12/2018	Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors.
12/2018	Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector.
11/2018	Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery.
1/2018	A Dual-Targeting Delivery System for Effective Genome Editing and In Situ Detecting Related Protein Expression in Edited Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Si-Xue Cheng Research Topics

Disease

69	Neoplasms (Cancer) 10/2023 - 01/2008
8	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2016
6	Circulating Neoplastic Cells 10/2023 - 10/2021
3	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2011
3	Hyperthermia 01/2019 - 03/2006
3	Inflammation (Inflammations) 03/2009 - 03/2006
2	Hypoxia (Hypoxemia) 01/2021 - 11/2020
1	Bites and Stings (Sting) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022
1	Adenocarcinoma 11/2022
1	Hepatitis B 07/2022
1	Hepatocellular Carcinoma (Hepatoma) 07/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Leukemia 01/2022
1	Melanoma (Melanoma, Malignant) 01/2021

Drug/Important Bio-Agent (IBA)

15	Peptides (Polypeptides)IBA 10/2023 - 02/2010
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
9	AGRO 100IBA 10/2023 - 01/2018
8	Hyaluronic Acid (Hyaluronan)IBA 10/2023 - 02/2016
8	PolymersIBA 12/2018 - 10/2008
8	Biotin (Vitamin H)FDA Link 01/2018 - 02/2008
7	MicellesIBA 03/2009 - 03/2006
6	LigandsIBA 11/2022 - 08/2009
6	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018 - 07/2008
5	AlbuminsIBA 01/2021 - 07/2015
5	Cell-Penetrating PeptidesIBA 10/2019 - 01/2013
5	Drug CarriersIBA 08/2015 - 02/2008
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2022
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2008
4	Photosensitizing Agents (Photosensitizers)IBA 11/2022 - 11/2015
4	AntigensIBA 11/2022 - 01/2020
4	Cadherins (E-Cadherin)IBA 01/2022 - 11/2018
4	Hydroxyl RadicalIBA 01/2021 - 10/2008
4	NucleolinIBA 11/2020 - 12/2018
4	GoldIBA 01/2020 - 11/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019 - 01/2018
4	VimentinIBA 07/2019 - 11/2018
4	Transferrin (beta 2 Transferrin)IBA 09/2015 - 02/2008
3	Messenger RNA (mRNA)IBA 10/2023 - 01/2020
3	Histones (Histone)IBA 01/2023 - 11/2020
3	Antineoplastic Agents (Antineoplastics)IBA 11/2022 - 10/2015
3	CytokinesIBA 07/2022 - 01/2017
3	Glutathione (Reduced Glutathione)IBA 01/2021 - 04/2013
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2021 - 01/2019
3	Protamines (Protamine Sulfate)FDA Link 01/2020 - 01/2017
3	Matrix Metalloproteinases (MMPs)IBA 07/2019 - 04/2013
3	MetalsIBA 12/2017 - 09/2017
3	AvidinIBA 06/2017 - 01/2013
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2016 - 10/2008
3	Silicon Dioxide (Silica)FDA LinkGeneric 01/2016 - 04/2013
3	Prednisone (Sone)FDA LinkGeneric 03/2009 - 03/2006
3	Acetates (Acetic Acid Esters)FDA Link 03/2009 - 03/2006
2	MicroRNAs (MicroRNA)IBA 10/2023 - 10/2021
2	Tumor Biomarkers (Tumor Markers)IBA 10/2023 - 01/2023
2	ErbB Receptors (EGF Receptor)IBA 10/2023 - 01/2023
2	Epithelial Cell Adhesion MoleculeIBA 01/2023 - 11/2018
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2023 - 12/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2021
2	Metal-Organic FrameworksIBA 11/2022 - 06/2020
2	Small Interfering RNA (siRNA)IBA 11/2022 - 07/2022
2	Bovine Serum AlbuminIBA 01/2021 - 11/2018
2	IntegrinsIBA 01/2021 - 01/2013
2	EnzymesIBA 01/2021 - 04/2019
2	Oxygen (Dioxygen)IBA 01/2021 - 11/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021 - 01/2019
2	CateninsIBA 04/2020 - 01/2019
2	SurvivinIBA 01/2020 - 01/2018
2	carboxymethyl-chitosanIBA 01/2020 - 06/2017
2	Focal Adhesion Protein-Tyrosine KinasesIBA 07/2019 - 12/2018
2	Therapeutic UsesIBA 01/2019 - 12/2017
2	OligodeoxyribonucleotidesIBA 01/2019 - 12/2017
2	CaspasesIBA 01/2019 - 12/2017
2	micaIBA 12/2018 - 12/2018
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	Mitochondrial DNA (mtDNA)IBA 01/2023
1	InterferonsIBA 01/2023
1	Cyclin-Dependent Kinase 4IBA 11/2022
1	Apoptosis Regulatory ProteinsIBA 11/2022
1	Interleukin-6 (Interleukin 6)IBA 07/2022
1	Antiviral Agents (Antivirals)IBA 07/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022
1	ribosomal protein L15IBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	AntioxidantsIBA 01/2021
1	aspartyl-phenylalanine (aspartylphenylalanine)IBA 01/2021
1	CatalaseIBA 01/2021
1	quinone (benzoquinone)IBA 01/2021
1	Cytochromes c (Cytochrome c)IBA 01/2021
1	ferroceneIBA 01/2021
1	phytochlorinIBA 01/2021

Therapy/Procedure

29	Therapeutics 10/2023 - 01/2013
9	Drug Therapy (Chemotherapy) 11/2022 - 06/2008
6	Immunotherapy 01/2023 - 08/2018
5	Photothermal Therapy 10/2019 - 01/2017
3	Photochemotherapy (Photodynamic Therapy) 01/2021 - 01/2019
3	Precision Medicine 06/2020 - 01/2016
2	Lasers (Laser) 01/2019 - 07/2008
1	Intravenous Administration 01/2021